1. Expert reveals how Queen could play key role if coronavirus vaccine becomes available  Express
  2. Russian disinformation aims to sow distrust over coronavirus vaccines  CBS Evening News
  3. North Carolina unveils plan to deploy coronavirus vaccine  WRAL.com
  4. India Selecting 300 Million People for Covid Vaccine, Times Says  Bloomberg
  5. Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60  Yahoo News
  6. View Full Coverage on Google News
THE QUEEN could play a key role if a coronavirus vaccine becomes available, according to an expert.THE QUEEN could play a key role if a coronavirus vaccine becomes available, according to an expert.

Queen news: Queen could play key role if coronavirus vaccine becomes available - expert | Royal | News | Express.co.uk

Bloomberg - Are you a robot?

India’s coronavirus infections rose by another 62,212 cases over the previous day and a local media report said on Saturday that the government had begun identifying about 300 million people who would be given the vaccine first when it is ready.India’s coronavirus infections rose by another 62,212 cases over the previous day and a local media report said on Saturday that the government had begun identifying about 300 million people who would be given the vaccine first when it is ready.

India begins selecting people for priority coronavirus vaccines | Reuters

Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.

Coronavirus: Experimental £46 COVID-19 vaccine is made available to residents of Chinese city | Daily Mail Online

North Carolina's Department of Health and Human Services unveiled a plan Friday in which it described the residents it will prioritize when a coronavirus vaccine gets approved and becomes available.North Carolina's Department of Health and Human Services unveiled a plan Friday in which it described the residents it will prioritize when a coronavirus vaccine gets approved and becomes available.

North Carolina unveils plan to deploy coronavirus vaccine :: WRAL.com

Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.

China's Covid-19 vax is safe, prompts antibody response: Lancet | greatandhra.com

A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus is safe and eli

Preliminary results show Chinese COVID-19 vaccine candidate safe: The Lancet - SHINE News

RALEIGH — The state Department of Health and Human Services unveiled a plan Friday in which it described the residents it will prioritize when a coronavirus…RALEIGH — The state Department of Health and Human Services unveiled a plan Friday in which it described the residents it will prioritize when a coronavirus vaccine gets approved and becomes available.

Vaccine distribution plan unveiled | Bladen Journal

MUMBAI: India’s coronavirus infections rose by another 62,212 cases over the previous day and a local media report said on Saturday that the government had begun identifying about 300 million people who would be given the vaccine first when it is ready. The Times of India said that frontline health and sanitation workers, police officials and elderly people with co-morbiditiesMUMBAI: India’s coronavirus infections rose by another 62,212 cases over the previous day and a local media report said on Saturday that the government had begun identifying about 300 million people

India begins selecting people for priority COVID-19 vaccines as over 60,000 more cases recorded | Arab News

A Chinese city is offering Sinovac Biotech's experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. The eastern city of Jiaxing's center for disease control and prevention (CDC) said in a statement on WeChat that two dosesA Chinese city is offering Sinovac Biotech's experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. The eastern city of Jiaxing's center for disease control and prevention (CDC) said in a statement on WeChat that two doses

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60

50 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-1950 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-19

50 African Diplomats on Anti-Covid-19 Visit to China’s Sinopharm | Africanews

Inspections will be carried out at 3 companies that have agreed to supply COVID-19 vaccines to Indonesia - Anadolu AgencyInspections will be carried out at 3 companies that have agreed to supply COVID-19 vaccines to Indonesia - Anadolu Agency

Indonesian team in China to check COVID-19 vaccines

A 50 euro double-dose experimental coronavirus vaccine has been made available to some residents in an eastern Chinese city, according to health officials, in the first mass distribution of an as-yet…A 50 euro double-dose experimental coronavirus vaccine has been made available to some residents in an eastern Chinese city, according to health officials, in the first mass distribution of an as-yet…

China starts distributing experimental Covid vaccine in eastern Jiaxing

A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.

Chinese COVID-19 vaccine candidate shows promise in human trial: Study | Health

China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad.China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad.

China rapidly expands use of experimental COVID-19 vaccines

Health authorities in Jiaxing, East China’s Zhejiang Province, announced on Thursday that the city has been administering China’s homegrown inactivated COVID-19 vaccines among high-risk groups and would gradually offer it to ordinary citizens for urgent use.

Eastern Chinese cities to offer ordinary citizens COVID-19 vaccines - Global Times

NewZimbabwe.com – The Zimbabwe News You Trust is Zimbabwe’s leading online newspaper and published by New Zimbabwe Media Ltd. The platform brings you the latest breaking News, Business, Showbiz, Sports, Diaspora and gives you everything you’ve come to expect and love.Spread This NewsMailOnLine Hopes of getting a Covid-19 vaccine were boosted again today after an experimental Chinese jab was found to be safe and produce an immune response. Every volunteer given a double-dose of state-owned firm Sinopharm’s vaccine made antibodies against SARS-CoV-2, the coronavirus that causes Covid-19. In theory, this would protect them from catching

More Covid-19 vaccine hopes as scientists say experimental Chinese jab is safe - NewZimbabwe.com

COVID-19 vaccine, and China-Africa health cooperation, are their focus.

50 African diplomats visit Chinese coronavirus vaccine maker - CGTN

Modi also cautioned against any complacency at the decline and called for keeping up the efforts to contain the pandemic.Modi also cautioned against any complacency at the decline and called for keeping up the efforts to contain the pandemic.

Coronavirus vaccine | Focus on cold storage chains, distribution network and monitoring mechanism, says PM - The Hindu

BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...

Study: Covid-19 vaccine candidate from China’s CNBG shows promise in human test | Life | Malay Mail

India News: As the world prepares for a vaccine against Covid-19, India has started identifying around 30 crore priority beneficiaries, including high-risk populIndia News: As the world prepares for a vaccine against Covid-19, India has started identifying around 30 crore priority beneficiaries, including high-risk popul

Covid-19: Govt identifying 30 crore who will get vaccine on priority | India News - Times of India

Once it reaches the market, Serum Institute will produce more doses to meet India’s requirement.Once it reaches the market, Serum Institute will produce more doses to meet India’s requirement.

Vaccine ready by December, in market by March: Serum Institute reveals Covid-19 vaccine planning - india news - Hindustan Times

Prime Minister Narendra Modi on Saturday reviewed Covid-19 pandemic situation in the country, preparedness of vaccine delivery, distribution & administration. The meeting was attended by Union Health Minister, Principal Secy to PM, Member (Health) NITI Aayog and other Depts of Govt of India.Prime Minister Narendra Modi on Saturday reviewed Covid-19 pandemic situation in the country, preparedness of vaccine delivery, distribution & administration. The meeting was attended by Union Health Minister, Principal Secy to PM, Member (Health) NITI Aayog and other Depts of Govt of India.

PM Modi reviews coronavirus vaccine delivery plan, calls for speedy access to all - Oneindia News

China is positioning itself to be key to any global solution to the pandemic.. Read more at straitstimes.com.East Asia News -China is positioning itself to be key to any global solution to the pandemic.. Read more at straitstimes.com.

Beijing in Covid-19 vaccine race to restore international image, East Asia News & Top Stories - The Straits Times

Results of BBIBP-CorV vaccine currently underway in UAE will provide information whether it is safe and efficacious.Results of BBIBP-CorV vaccine currently underway in UAE will provide information whether it is safe and efficacious.

Chinese Covid-19 vaccine found to be safe on humans: Study - News | Khaleej Times

The group says they have also built the largest cold chain network and distribution system to safely transport and store vaccine

Apollo ready to administer 1 million COVID-19 vaccines a day

Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59

Preliminary results show Chinese Covid-19 vaccine candidate safe | Dhaka Tribune

Scientists have warned that governments and tech firms need to tackle coronavirus misinformation.Scientists have warned that governments and tech firms need to tackle coronavirus misinformation.

Queen could help boost public’s trust in coronavirus vaccine, expert says | ITV News

Serum Institute of India's Executive Director has said that India will have 200-300 million doses of coronavrirus vaccine by the end of December this year.Serum Institute of India's Executive Director has said that India will have 200-300 million doses of coronavrirus vaccine by the end of December this year.

India to have 200-300 mn Covid vaccine doses ready by December end, says SII Executive Director - India News

India may get a Covid-19 vaccine as early as March since several manufacturers are working on it, according to Dr Suresh Jadhav, executive director of Serum Institute of India. The institute is working with Oxford University and AstraZeneca to develop a Covid-19 vaccine in India.India may get a Covid-19 vaccine as early as March since several manufacturers are working on it, according to Dr Suresh Jadhav, executive director of Serum Institute of India. The institute is

India may get Covid-19 vaccine by March: Serum Institute of India official | Deccan Herald

Nation’s broken health-care system cannot cope with strain of prolonged pandemicNation’s broken health-care system cannot cope with strain of prolonged pandemic

Report: India selecting 300m people for COVID-19 vaccine | India – Gulf News

China has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said theChina has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said the

Currently, scientists, health researchers and drugmakers all over the world are racing to produce a safe and effective vaccine against coronavirus.Currently, scientists, health researchers and drugmakers all over the world are racing to produce a safe and effective vaccine against coronavirus.

Clinical trials of the coronavirus vaccine have involved 640 peopleClinical trials of the coronavirus vaccine have involved 640 people

Chinese Covid-19 vaccine candidate safe, early reports say | Metro News

Serum Institute of India can produce 700-800 million vaccine dosages every year once things are streamlined, executive director of SII said.The vaccine is likely to provide protection for about a year, AstraZeneca CEO Pascal Soriot saidSerum Institute of India can produce 700-800 million vaccine dosages every year once things are streamlined, executive director of SII said.The vaccine is likely to provide protection for about a year, AstraZeneca CEO Pascal Soriot said

COVID-19 vaccine may be ready by December, to be available in market by March: SII official

The move is aimed at boosting public confidence in homegrown inoculations, the WSJ reported, citing a company website and some students who applied for it.

China's Sinopharm Offers Experimental COVID-19 Vaccines to Students - The Wire Science

India is in the process of finalising a top priority list of nearly 30 crore people, including health workers, police personnel, sanitation workers, the elderly and people with co-morbidities for getting an estimated 60 crore Covid-19 vaccine shots. "The first list is expected to be ready by this month-end or early November," a Health Ministry official said. The initial phaseIndia is in the process of finalising a top priority list of nearly 30 crore people, including health workers, police personnel, sanitation workers, the elderly and people with co-morbidities for

India finalising list of 30 crore for Covid-19 vaccine | The Daily Star

Hope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet Infectious Disease, is based on small early phase randomised clinical trials involving 640 participants. The vaccine candidate is based on inactivated coronavirus. Scientists said thoseHope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet

Hope for coronavirus vaccine boosted as scientists say Chinese jab safe and produces immune response | London Evening Standard

Researchers caution that levels of antibodies produced in participants aged over 60 were lower and took longer to increase, however Researchers caution that levels of antibodies produced in participants aged over 60 were lower and took longer to increase, however 

Chinese coronavirus vaccine shows promising results in human tests, study shows | The Independent

The market leader in flu vaccines is trailing in the race to find an effective coronavirus vaccine.The market leader in flu vaccines is trailing in the race to find an effective coronavirus vaccine.

Sanofi and Translate Bio Have a COVID-19 Vaccine Candidate Ready for Clinical Trials | The Motley Fool

Dr Suresh Jadhav, executive director of the Serum Institute of India, told The Indian Express that India is heading fast towards vaccine development, as two manufacturers are already in phase-3 trial and one in the phase-2 trial, and more players are joining the race.Dr Suresh Jadhav, executive director of the Serum Institute of India, told The Indian Express that India is heading fast towards vaccine development, as two manufacturers are already in phase-3 trial and one in the phase-2 trial, and more players are joining the race.

India may get Covid vaccine by March, says Serum official | India News,The Indian Express

BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...

US$60 experimental COVID-19 vaccine rolled out in east Chinese city - CNA

Serum Institute of India (SII) can manufacture 700-800 million vaccine doses every year. said executive director Dr Suresh Jadhav.Serum Institute of India (SII) can manufacture 700-800 million vaccine doses every year. said executive director Dr Suresh Jadhav.

Oxford COVID-19 vaccine likely to be ready by March 2021: Serum Institute of India